Document:

EX-10.8

 Exhibit 10.8 

DIRECTOR NOMINATION AGREEMENT 

THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of [•], 2021, by and among Instructure
Holdings, Inc., a Delaware corporation (the “Company”), Thoma Bravo Fund XIII, L.P., a Delaware limited partnership, Thoma Bravo Fund XIII-A, L.P., a Delaware limited partnership, Thoma Bravo
Executive Fund XIII, L.P., a Delaware limited partnership, Thoma Bravo Partners XIII, L.P., and Thoma Bravo UGP, LLC, a Delaware limited liability company (collectively, “Thoma Bravo”). This Agreement shall become effective (the
“Effective Date”) upon the closing of the Company’s proposed initial public offering (the “IPO”) of shares of its Common Stock (as defined below). 

WHEREAS, as of the date hereof, Thoma Bravo beneficially owns a majority of the equity interests in the Company; 

WHEREAS, Thoma Bravo is contemplating causing the Company to effect an IPO; 

WHEREAS, Thoma Bravo currently has the authority to appoint all directors of the Company; 

WHEREAS, in consideration of Thoma Bravo agreeing to undertake the IPO, the Company has agreed to permit Thoma Bravo to designate persons for
nomination for election to the board of directors of the Company (the “Board”) following the Effective Date on the terms and conditions set forth herein; 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, each of the parties to this Agreement agrees as follows: 
 1.    Board
Nomination Rights. 
 (a)    From the Effective Date, Thoma Bravo shall have the right, but not the obligation, to
nominate to the Board a number of designees equal to at least: (i) 100% of the Total Number of Directors (as defined below), so long as Thoma Bravo continuously from the time of the IPO Beneficially Owns shares of common stock, par value $0.01 per
share (the “Common Stock”) representing at least 40% of the Original Amount of Thoma Bravo, (ii) 40% of the Total Number of Directors, in the event that Thoma Bravo continuously from the time of the IPO Beneficially Owns shares of
Common Stock representing at least 30% but less than 40% of the Original Amount of Thoma Bravo, (iii) 30% of the Total Number of Directors, in the event that Thoma Bravo continuously from the time of the IPO Beneficially Owns shares of Common Stock
representing at least 20% but less than 30% of the Original Amount of Thoma Bravo, (iv) 20% of the Total Number of Directors, in the event that Thoma Bravo continuously from the time of the IPO Beneficially Owns shares of Common Stock representing
at least 10% but less than 20% of the Original Amount of Thoma Bravo and (v) one Director, in the event that Thoma Bravo continuously from the time of the IPO Beneficially Owns shares of Common Stock representing at least 5% of the Original
Amount of Thoma Bravo (such persons, the “Nominees”). For purposes of calculating the number of directors that Thoma Bravo is entitled to designate pursuant to the immediately preceding sentence, any fractional amounts shall
automatically be rounded up to the nearest whole number (e.g., 11⁄4 Directors shall equate to 2 Directors) and any such calculations shall be made after taking into
account any increase in the Total Number of Directors. 

 (b)    In the event that Thoma Bravo has nominated less than the total
number of designees Thoma Bravo shall be entitled to nominate pursuant to Section 1(a), Thoma Bravo shall have the right, at any time, to nominate such additional designees to which it is entitled, in which case, the
Company and the Directors shall take all necessary corporation action (including increasing the size of the Board to create a vacancy), to the fullest extent permitted by applicable law (including with respect to fiduciary duties under Delaware
law), to (x) enable Thoma Bravo to nominate and effect the election or appointment of such additional individuals, whether by increasing the size of the Board, or otherwise and (y) to designate such additional individuals nominated by
Thoma Bravo to fill such newly created vacancies or to fill any other existing vacancies. 
 (c)    In addition to the
nomination rights set forth in Section 1(a) above, from the Effective Date, for so long as Thoma Bravo continuously from the time of the IPO Beneficially Owns shares of Common Stock representing at least 5% of the Original
Amount of Thoma Bravo, Thoma Bravo shall have the right, but not the obligation, to designate a person (a “Non-Voting Observer”) to attend meetings of the Board (including any meetings of any
committees thereof) in a non-voting observer capacity. Any such Non-Voting Observer shall be permitted to attend all meetings of the Board. Thoma Bravo shall have the
right to remove and replace its Non-Voting Observer at any time and from time to time. The Company shall furnish to any Non-Voting Observer (i) notices of Board
meetings no later than, and using the same form of communication as, notice of Board meetings are furnished to directors and (ii) copies of any materials prepared for meetings of the Board that are furnished to the directors no later than the
time such materials are furnished to the directors; provided that failure to deliver notice, or materials, to such Non-Voting Observer in connection with such Non-Voting
Observer’s right to attend and/or review materials with respect to, any meeting of the Board shall not, by itself, impair the validity of any action taken by such Board at such meeting. Such Non-Voting
Observer shall be required to execute or otherwise become subject to any codes of conduct or confidentiality agreements of the Company generally applicable to directors of the Company or as the Company reasonably requests. Notwithstanding the
foregoing, the Company reserves the right to withhold any information and to exclude the Non-Voting Observer from receiving any materials and/or attending any meeting or portion thereof if access to such
information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel. 

(d)    The Company shall pay all reasonable
out-of-pocket expenses incurred by the Nominees and the Non-Voting Observer in connection with the performance of his or her
duties as a director or a Non-Voting Observer and in connection with his or her attendance at any meeting of the Board. 

(e)    “Affiliate” of any person shall mean any other person controlled by, controlling or under common
control with such person; where “control” (including, with its correlative meanings, “controlling,” “controlled by” and “under common control with”) means possession, directly or
indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities, by contract or otherwise). 

  
 2 

 (f)    “Beneficially Own” shall mean that a specified
person has or shares the right, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, to vote shares of capital stock of the Company. 

(g)    “Director” means any member of the Board. 

(h)    “Original Amount of Thoma Bravo” means the aggregate number of shares of Common Stock held,
directly or indirectly, by Thoma Bravo on the date hereof, as such number may be adjusted from time to time for any reorganization, recapitalization, stock dividend, stock split, reverse stock split or other similar changes in the Company’s
capitalization. 
 (i)    “Total Number of Directors” means the total number of Directors comprising
the Board. 
 (j)    No reduction in the number of shares of Common Stock that Thoma Bravo Beneficially Owns shall
shorten the term of any incumbent director. At the Effective Date, the Board shall be comprised of seven members and the initial Nominees shall be Steve Daly, Charles Goodman, Erik Akopiantz, Ossa Fisher, James Hutter, Brian Jaffee and Paul Holden
Spaht, Jr. 
 (k)    In the event that any Nominee shall cease to serve for any reason, Thoma Bravo shall be entitled to
designate such person’s successor in accordance with this Agreement (regardless of Thoma Bravo’s beneficial ownership in the Company at the time of such vacancy) and the Board shall promptly fill the vacancy with such successor nominee; it
being understood that any such designee shall serve the remainder of the term of the director whom such designee replaces. 

(l)    If a Nominee is not appointed or elected to the Board because of such person’s death, disability,
disqualification, withdrawal as a nominee or for other reason is unavailable or unable to serve on the Board, Thoma Bravo shall be entitled to designate promptly another nominee and the director position for which the original Nominee was nominated
shall not be filled pending such designation. 
 (m)    So long as Thoma Bravo has the right to nominate Nominees under
Section 1(a) or any such Nominee is serving on the Board, the Company shall use its reasonable best efforts to maintain in effect at all times directors and officers indemnity insurance coverage reasonably satisfactory to Thoma Bravo, and the
Company’s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws (each as may be further amended, supplemented or waived in accordance with its terms) shall at all times provide for indemnification, exculpation and
advancement of expenses to the fullest extent permitted under applicable law. 
 (n)    If the size of the Board is
expanded, Thoma Bravo shall be entitled to nominate a number of Nominees to fill the newly created vacancies such that the total number of Nominees serving on the Board following such expansion will be equal to that number of Nominees that Thoma
Bravo would be entitled to nominate in accordance with Section 1(a) if such expansion occurred immediately prior to any meeting of the stockholders of the Company called with respect to the election of members of the Board,
and the Board shall appoint such Nominees to the Board. 

  
 3 

 (o)    At such time as the Company ceases to be a “controlled
company” and is required by applicable law or The New York Stock Exchange (the “Exchange”) listing standards to have a majority of the Board comprised of “independent directors” (subject in each case to any applicable
phase-in periods), Thoma Bravo’s Nominees shall include a number of persons that qualify as “independent directors” under applicable law and the Exchange listing standards such that, together
with any other “independent directors” then serving on the Board that are not Nominees, the Board is comprised of a majority of “independent directors.” 

(p)    At any time that Thoma Bravo shall have any nomination rights under Section 1, the
Company shall not take any action, including making or recommending any amendment to the Amended and Restated Certificate of Incorporation or the Company’s Amended and Restated Bylaws that could reasonably be expected to adversely affect Thoma
Bravo’s rights under this Agreement, in each case without the prior written consent of Thoma Bravo. 

2.    Company Obligations. The Company agrees to use its reasonable best efforts to ensure that prior to the date
that Thoma Bravo and its Affiliates cease to Beneficially Own shares of Common Stock representing at least 5% of the total voting power of the then outstanding Common Stock, (i) each Nominee is included in the Board’s slate of nominees to
the stockholders (the “Board’s Slate”) for each election of directors; and (ii) each Nominee is included in the proxy statement prepared by management of the Company in connection with soliciting proxies for every meeting
of the stockholders of the Company called with respect to the election of members of the Board (each, a “Director Election Proxy Statement”), and at every adjournment or postponement thereof, and on every action or approval by
written consent of the stockholders of the Company or the Board with respect to the election of members of the Board. Thoma Bravo will promptly provide reporting to the Company after Thoma Bravo ceases to Beneficially Own shares of Common Stock
representing at least 5% of the total voting power of the then outstanding Common Stock, such that Company is informed of when this obligation terminates. The calculation of the number of Nominees that Thoma Bravo is entitled to nominate to the
Board’s Slate for any election of directors shall be based on the percentage of the total voting power of the then outstanding Common Stock then Beneficially Owned by Thoma Bravo (“Thoma Bravo Voting Control”) immediately prior
to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission). Unless Thoma Bravo
notifies the Company otherwise prior to the mailing to shareholders of the Director Election Proxy Statement relating to an election of directors, the Nominees for such election shall be presumed to be the same Nominees currently serving on the
Board, and no further action shall be required of Thoma Bravo for the Board to include such Nominees on the Board’s Slate; provided, that, in the event Thoma Bravo is no longer entitled to nominate the full number of Nominees then serving on
the Board, Thoma Bravo shall provide advance written notice to the Company, of which currently servicing Nominee(s) shall be excluded from the Board Slate, and of any other changes to the list of Nominees. If Thoma Bravo fails to provide such notice
prior to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission), a majority

  
 4 

 
of the independent directors then serving on the Board shall determine which of the Nominees of Thoma Bravo then serving on the Board will be included in the Board’s Slate. Furthermore, the
Company agrees for so long as the Company qualifies as a “controlled company” under the rules of the Exchange the Company will elect to be a “controlled company” for purposes of the Exchange and will disclose in its annual
meeting proxy statement that it is a “controlled company” and the basis for that determination. The Company and Thoma Bravo acknowledge and agree that, as of the Effective Date, the Company is a “controlled company.” 

3.    Committees. From and after the Effective Date hereof until such time as Thoma Bravo and its Affiliates cease
to Beneficially Own shares of Common Stock representing at least 5% of the total voting power of the then outstanding Common Stock, Thoma Bravo shall have the right to designate a number of members of each committee of the Board equal to the nearest
whole number greater than the product obtained by multiplying (a) the percentage of the total voting power of the then outstanding Common Stock then Beneficially Owned by Thoma Bravo and (b) the number of positions, including any
vacancies, on the applicable committee, provided that any such designee shall be a director and shall be eligible to serve on the applicable committee under applicable law or listing standards of the Exchange, including any applicable independence
requirements (subject in each case to any applicable exceptions, including those for newly public companies and for “controlled companies,” and any applicable phase-in periods). Any additional
members shall be determined by the Board. Nominees designated to serve on a Board committee shall have the right to remain on such committee until the next election of directors, regardless of the level of Thoma Bravo Voting Control following such
designation. Unless Thoma Bravo notifies the Company otherwise prior to the time the Board takes action to change the composition of a Board committee, and to the extent Thoma Bravo has the requisite Thoma Bravo Voting Control for Thoma Bravo to
nominate a Board committee member at the time the Board takes action to change the composition of any such Board committee, any Nominee currently designated by Thoma Bravo to serve on a committee shall be presumed to be re-designated for such committee. 
 4.    Amendment and Waiver. Any provision
of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by the Company and Thoma Bravo, or in the case of a waiver, by the party against whom the waiver is to be
effective. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of
any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law. Thoma Bravo shall not be obligated to nominate all (or any) of the Nominees it is entitled
to nominate pursuant to this Agreement for any election of directors but the failure to do so shall not constitute a waiver of its rights hereunder with respect to future elections; provided, however, that in the event Thoma Bravo
fails to nominate all (or any) of the Nominees it is entitled to nominate pursuant to this Agreement prior to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the
definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission), the Compensation and Governance Committee of the Board shall be entitled to nominate individuals in lieu of such Nominees for inclusion in the
Board’s Slate and the applicable Director Election Proxy Statement with respect to the election for which such failure occurred and Thoma 

  
 5 

 
Bravo shall be deemed to have waived its rights hereunder with respect to such election. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies
provided by law. 
 5.     Benefit of Parties. This Agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their respective permitted successors and assigns. Notwithstanding the foregoing, the Company may not assign any of its rights or obligations hereunder without the prior written consent of Thoma Bravo. Except as
otherwise expressly provided in Section 6, nothing herein contained shall confer or is intended to confer on any third party or entity that is not a party to this Agreement any rights under this Agreement. 

6.    Assignment. Upon written notice to the Company, Thoma Bravo may assign to any any Affiliate of Thoma Bravo
(other than a portfolio company) all of its rights hereunder and, following such assignment, such assignee shall be deemed to be “Thoma Bravo” for all purposes hereunder. 

7.    Indemnification. 

(a)    The Company shall defend, indemnify and hold harmless Thoma Bravo, its Affiliates, partners, employees, agents,
directors, managers, officers and controlling Persons (collectively, the “Indemnified Parties”) from and against any and all actions, causes of action, suits, claims, liabilities, losses, damages, costs, expenses, or obligations of
any kind or nature (whether accrued or fixed, absolute or contingent) in connection therewith (including reasonable attorneys’ fees and expenses) incurred by the Indemnified Parties before or after the date of this Agreement (each, an
“Action”) arising directly or indirectly out of, or in any way relating to, (i) Thoma Bravo’s or its Affiliates’ Beneficial Ownership of Common Stock or other equity securities of the Company or control or ability to
influence the Company or any of its subsidiaries (other than any such Actions (x) to the extent such Actions arise out of any breach of this Agreement by an Indemnified Party or its Affiliates or the breach of any fiduciary or other duty or
obligation of such Indemnified Party to its direct or indirect equity holders, creditors or Affiliates or (y) to the extent such Actions are directly caused by such Person’s willful misconduct), (ii) the business, operations, properties,
assets or other rights or liabilities of the Company or any of its subsidiaries or (iii) any services provided prior, on or after the date of this Agreement by Thoma Bravo or its Affiliates to the Company or any of its subsidiaries. The Company
shall defend at its own cost and expense in respect of any Action which may be brought against the Company and/or its Affiliates and the Indemnified Parties. The Company shall defend at its own cost and expense any and all Actions which may be
brought in which the Indemnified Parties may be impleaded with others upon any Action by the Indemnified Parties, except that if such damage shall be proven to be the direct result of gross negligence, bad faith or willful misconduct by any of the
Indemnified Parties, then such Indemnified Party shall reimburse the Company for the costs of defense and other costs incurred by the Company in proportion to such Indemnified Party’s culpability as proven. In the event of the assertion against
any Indemnified Party of any Action or the commencement of any Action, the Company shall be entitled to participate in such Action and in the investigation of such Action and, after written notice from the Company to such Indemnified Party, to
assume the investigation or defense of such Action with counsel of the Company’s choice at the Company’s expense; provided, however, that such counsel shall be reasonably satisfactory to the Indemnified

  
 6 

 
Party. Notwithstanding anything to the contrary contained herein, the Company may retain one firm of counsel to represent all Indemnified Parties in such Action; provided, however, that the
Indemnified Party shall have the right to employ a single firm of separate counsel (and any necessary local counsel) and to participate in the defense or investigation of such Action and the Company shall bear the expense of such separate counsel
(and local counsel, if applicable), if (x) in the opinion of counsel to the Indemnified Party use of counsel of the Company’s choice could reasonably be expected to give rise to a conflict of interest, (y) the Company shall not have
employed counsel satisfactory to the Indemnified Party to represent the Indemnified Party within a reasonable time after notice of the assertion of any such Action or (z) the Company shall authorize the Indemnified Party to employ separate
counsel at the Company’s expense. The Company further agrees that with respect to any Indemnified Party who is employed, retained or otherwise associated with, or appointed or nominated by, Thoma Bravo or any of its Affiliates and who acts or
serves as a director, officer, manager, fiduciary, employee, consultant, advisor or agent of, for or to the Company or any of its subsidiaries, that the Company or such subsidiaries, as applicable, shall be primarily liable for all indemnification,
reimbursements, advancements or similar payments (the “Indemnity Obligations”) afforded to such Indemnified Party acting in such capacity or capacities on behalf or at the request of the Company, whether the Indemnity Obligations
are created by law, organizational or constituent documents, contract (including this Agreement) or otherwise. The Company hereby agrees that in no event shall the Company or any of its subsidiaries have any right or claim against Thoma Bravo for
contribution or have rights of subrogation against Thoma Bravo through an Indemnified Party for any payment made by the Company or any of its subsidiaries with respect to any Indemnity Obligation. In addition, the Company hereby agrees that in the
event that Thoma Bravo pay or advance an Indemnified Party any expenses with respect to an Indemnity Obligation, the Company will, or will cause its subsidiaries to, as applicable, promptly reimburse Thoma Bravo, for such payment or advance upon
request; subject to the receipt by the Company of a written undertaking executed by the Indemnified Party and Thoma Bravo, that makes such payment or advance to repay any such amounts if it shall ultimately be determined by a court of competent
jurisdiction that such Indemnified Party was not entitled to be indemnified by the Company. The foregoing right to indemnity shall be in addition to any rights that any Indemnified Party may have at common law or otherwise and shall remain in full
force and effect following the completion or any termination of the engagement. If for any reason the foregoing indemnification is unavailable to any Indemnified Party or insufficient to hold it harmless as and to the extent contemplated by this
Section 7, then the Company shall contribute to the amount paid or payable by the Indemnified Party as a result of such Action in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and
the Indemnified Party, as the case may be, on the other hand, as well as any other relevant equitable considerations. 

(b)    The Company hereby acknowledges that the certain of the Indemnified Parties have certain rights to indemnification,
advancement of expenses and/or insurance provided by investment funds managed by Thoma Bravo and certain of their Affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees with respect to any indemnification, hold
harmless obligation, expense advancement or reimbursement provision or any other similar obligation whether pursuant to or with respect to this Agreement, the organizational documents of the Company or any of its subsidiaries or any other agreement,
as applicable, (i) that the Company and its subsidiaries are the indemnitor of first resort (i.e., their obligations to the Indemnified 

  
 7 

 
Parties are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for claims, expenses or obligations arising out of the same or similar facts and
circumstances suffered by any Indemnified Party are secondary), (ii) that the Company shall be required to advance the full amount of expenses incurred by any Indemnified Party and shall be liable for the full amount of all expenses, liabilities,
obligations, judgments, penalties, fines, and amounts paid in settlement to the extent legally permitted and as required by the terms of this Agreement, the organizational documents of the Company or any of its subsidiaries or any other agreement,
as applicable, without regard to any rights any Indemnified Party may have against the Fund Indemnitors, and (iii) that the Company, on behalf of itself and each of its subsidiaries, irrevocably waives, relinquishes and releases the Fund
Indemnitors from any and all Actions against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of any
Indemnified Party with respect to any Action for which any Indemnified Party has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of
such advancement or payment to all of the rights of recovery of any Indemnified Party against the Company. The Company agrees that the Fund Indemnitors are express third-party beneficiaries of the terms of this Section 7(b). 

8.    Headings. Headings are for ease of reference only and shall not form a part of this Agreement. 

9.    Governing Law. This Agreement shall be construed in accordance with and governed by the law of the State of
Delaware without giving effect to the principles of conflicts of laws thereof. 
 10.    Jurisdiction. Any suit,
action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement may be brought against any of the parties in any federal court located in the State of Delaware or any Delaware
state court, and each of the parties hereby consents to the exclusive jurisdiction of such court (and of the appropriate appellate courts) in any such suit, action or proceeding and waives any objection to venue laid therein. Process in any such
suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each of the parties agrees that service of process upon such party at the
address referred to in Section 16, together with written notice of such service to such party, shall be deemed effective service of process upon such party. 

11.    WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT. 
 12.    Entire Agreement.
This Agreement constitutes the entire agreement among the parties with respect to the subject matter hereof and supersedes all prior agreements, understandings and negotiations, both written and oral among the parties with respect to the subject
matter hereof. 

  
 8 

 13.    Counterparts; Effectiveness. This Agreement may be signed
in any number of counterparts, each of which shall be deemed an original. This Agreement shall become effective when each party shall have received a counterpart hereof signed by each of the other parties. An executed copy or counterpart hereof
delivered by facsimile shall be deemed an original instrument. 
 14.    Severability. If any provision of this
Agreement or the application thereof to any person or circumstance shall be invalid or unenforceable to any extent, the remainder of this Agreement and the application of such provisions to other persons or circumstances shall not be affected
thereby and shall be enforced to the greatest extent permitted by law. 
 15.    Further Assurances. Each of the
parties hereto shall execute and deliver such further instruments and do such further acts and things as may be required to carry out the intent and purpose of this Agreement. 

16.    Specific Performance. Each of the parties hereto agree that irreparable damage would occur if any provision
of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and
provisions hereof in any federal or state court located in the State of Delaware, in addition to any other remedy to which they are entitled at law or in equity. 

17.    Notices. All notices, requests and other communications to any party or to the Company shall be in writing
(including telecopy or similar writing) and shall be given, 
 If to the Company: 

Instructure Holdings, Inc. 
 6330
South 3000 East, Suite 7000 
 Salt Lake City, UT 84121 

Attention: Matt Kaminer, Chief Legal Officer 

Email: mkaminer@instructure.com 

With a copy to (which shall not constitute notice): 

Kirkland & Ellis LLP 

300 North LaSalle Street 

Chicago, IL 60654 
 Attention:
Bradley C. Reed, P.C. 
                  Michael P. Keeley

 Email: bradley.reed@kirkland.com; michael.keeley@kirkland.com 

If to any member of Thoma Bravo or any Nominee: 

c/o Thoma Bravo, L.P 
 600
Montgomery Street, 20th Floor 
 San Francisco, CA 94111 

Attention: Holden Spaht 

                 Brian Jaffee 

Email: hsphat@thomabravo.com; bjaffee@thomabravo.com 

  
 9 

 With a copy to (which shall not constitute notice): 

Kirkland & Ellis LLP 

300 North LaSalle Street 

Chicago, IL 60654 
 Attention:
Bradley C. Reed, P.C. 
                  Michael P. Keeley

 Email: bradley.reed@kirkland.com; michael.keeley@kirkland.com 

or to such other address or telecopier number as such party or the Company may hereafter specify for the purpose by notice to the other parties and the
Company. Each such notice, request or other communication shall be effective when delivered at the address specified in this Section 16 during regular business hours. 

18.    Enforcement. Each of the parties hereto covenant and agree that the disinterested members of the Board have
the right to enforce, waive or take any other action with respect to this Agreement on behalf of the Company. 

*    *    *    *    * 

  
 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date first above
written. 
  

			
	INSTRUCTURE HOLDINGS, INC.
		
	By:	 	  

	Name:	 	Dale Bowen
	Title:	 	Chief Financial Officer
	
	[THOMA BRAVO SIG BLOCKS]

 [Signature Page to Director Nomination Agreement]EX-10.9

 Exhibit 10.9 
  

 
 MAY 8, 2020 
 Steve Daly 

Dear Steve, 
 Instructure, Inc. (the “Company”) is
pleased to offer you a full-time position as of Chief Executive Officer according to the following terms. 
 DUTIES 

You will be responsible for duties as are ordinary, customary and necessary in the CEO role and as the board may direct. 

BASE COMPENSATION 
 Your base compensation will be $450,000 per
year paid in substantially equal installments, less payroll deductions and all required withholdings (“Base Salary”). You will be paid semi-monthly in accordance with the Company’s current payroll practices, which may change from time
to time. Pay dates currently fall on the 15th and 31st (or last day) of each month. 
 ANNUAL LEADERSHIP BONUS PROGRAM 

Each year, you will be eligible to participate in the Company Executive bonus program at a target rate of 100 % of your Base Salary for the performance
year. Bonus payout will be funded based on EBITDA targets and allocated based on Company and individual performance and will be pro-rated based on hire date. This bonus will be governed by the terms and
conditions of the Executive Bonus Program summary to be provided. 
 NEW HIRE EQUITY GRANT 

In connection with the commencement of your employment, The Company will recommend to the Board of Directors that they grant you 2.5% of Class B Units of
Instructure Parent, LP at no cost. Instructure Parent, LP is the ultimate parent entity and holding company that owns the Company. The granted equity will vest over four years subject to a combination of performance and your continued service to the
Company. 
 BENEFITS 
 You, and your qualified dependents, will
be eligible for the standard Company benefits based on the terms and conditions of the benefit plans and applicable policies. Details about these benefit plans will be available for your review. Pursuant to Company policy, you will not accrue
vacation time, and you may instead be eligible to take time off with pay as appropriate for your position and workload. The Company may modify compensation and benefits from time to time, as it deems necessary in its sole discretion. 

 

 
  

			
	Quick Info
		
	Title	  	Chief Executive Officer
		
	Start Date	  	July 1, 2020
		
	Benefits	  	 Medical, Dental, Vision, Disability Insurance,

Life, 401k w/ match, Gym Membership, Time Off with Pay

		
	Holidays	  	9 Paid Holidays

 RULES AND POLICIES 
 As a Company
employee, you will be expected to abide by Company rules and policies as they are adopted and amended from time to time and sign and comply with the attached Confidentiality and Intellectual Property Agreement which, among other obligations,
prohibits unauthorized use or disclosure of the Company’s proprietary information and solicitation of its employees and customers (to the extent allowed by law). 

PROPRIETARY INFORMATION 
 In your work for the Company, you will
be expected not to use or disclose any confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of confidentiality. Rather, you will be expected to use only that information which is
generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. You represent
that you will be able to perform your job duties within the guidelines just described and that you have disclosed to the Company any contract you have signed that may restrict your activities on behalf of the Company. You agree that you will not
bring onto the Company’s premises, nor upload onto the Company’s computer systems, any unpublished documents, confidential information, or property belonging to any former employer or other person to whom you have an obligation of
confidentiality. 
 AT-WILL EMPLOYMENT 
 The Company’s
employees are employed “at-will”, employed for no specific period of time, and employment may be terminated by the Company or the employee at any time, with or without cause, and with or without advance notice. This employment at-will
status cannot be altered in any way by any oral or written statements, policies or practices and can only be altered or modified by a written employment contract signed by you and the CEO of the Company. 

SEVERANCE 
 In the event that the Company terminates your
employment without Cause, and if you first sign, date, and deliver to the Company a separation agreement that includes a general release of all known and unknown claims in the form provided to you by the Company, and allow this separation agreement
to become effective, then you will receive, as your sole severance benefits: (i) severance pay equal to twelve (12) months of your base salary in effect as of the termination date, less required deductions and withholdings, paid in the
form of salary continuation on the Company’s standard payroll dates (beginning with the first payroll date following the effective date of the required 

 

 
  

 
separation agreement); and (ii) provided that you timely elect continued group health insurance coverage through COBRA, the Company will pay your COBRA premiums sufficient to continue your
group health insurance coverage at the same level in effect as of your termination date for six (6) months after your termination or until you become eligible for group health insurance coverage through a new employer, whichever occurs first.

 For purposes of this Section, “Cause” means any of the following conduct by you: (i) embezzlement, misappropriation of corporate funds, or
other material acts of dishonesty; (ii) commission or conviction of any felony, or of any misdemeanor involving moral turpitude, or entry of a plea of guilty or nolo contendere to any felony or misdemeanor involving moral turpitude;
(iii) engagement in any activity that you know or should know could materially harm the business or reputation of the Company; (iv) material failure to adhere to the Company’s corporate codes, policies or procedures as in effect from
time to time and your failure to cure such violations within thirty (30) days; (v) material violation of any statutory, contractual, or common law duty or obligation to the Company, including, without limitation, the duty of loyalty;
(vi) material breach of the Confidentiality Agreement; or (vii) repeated failure, in the reasonable judgment of the Company, to substantially perform your assigned duties or responsibilities after written notice from the Company and your
failure to cure such failure(s) within thirty (30) days of receiving such written notice, provided that written notice only must be provided if the failure(s) are capable of cure. 

CONTINGENCIES 
 This offer is contingent upon proof of
identification and work authorization as required by the Immigration Reform and Control Act of 1986. It is also contingent on completion of a pre-employment background check and reference check, with results satisfactory to the Company. You agree to
assist as needed and to complete any documentation at the Company’s request to meet these conditions. 
 MISCELLANEOUS 

This letter, together with your Confidentiality and Intellectual Property Agreement, provides important information associated with your employment and is the
complete, final and exclusive agreement between you and the Company. You enter into this agreement without relying upon any promise, warranty, representation, or agreement, written or oral, other than those expressly contained within. The employment
terms of this agreement supersede any other agreements or promises made to you by anyone, whether oral or written. Also, this agreement cannot be changed except in a writing signed by you and a duly authorized officer of the Company and electronic
signatures shall be equivalent to original signatures. 
 Please sign and date this letter, and return it to me if you wish to accept employment at the
Company under the terms described above. If you accept our offer, we anticipate you starting on July 1, 2020. 
 We look forward to your favorable
reply and to a productive and enjoyable work relationship. 
  

			
	 Sincerely,
 INSTRUCTURE, INC.
	 	
		
	/s/ Charles Goodman	 	/s/ Steve Daly
		 	Steve Daly
		
	Charles Goodman	 	
	Chairman	 	Accepted:

 

 
  

 CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENT 

In consideration of my employment or continued employment by Instructure, Inc. (“Company”), and the compensation now and hereafter paid to me, I
hereby agree to the terms of this agreement (the “Agreement”) as follows: 
  

	1.	 Nondisclosure. 

(a)    Nondisclosure. At all times during my employment and thereafter, I will hold in strictest confidence and will not disclose,
use, lecture upon or publish any of Company’s Proprietary or Confidential Information (defined below), except as such disclosure, use or publication may be required in connection with my work for Company, or unless an officer of Company
expressly authorizes such in writing. I will obtain Company’s written approval before publishing or submitting for publication any material (written, verbal, or otherwise) that relates to my work at Company and/or incorporates any Proprietary
or Confidential Information. I hereby assign to Company any rights I may have or acquire in such Confidential Information and recognize that all Confidential Information shall be the sole property of the Company and its assigns. 

(b)    Confidential Information. The term “Confidential Information” means any documentation, data, or information which
is valuable to the Company and not generally known to the public, including but not limited to any and all knowledge, data or information related to Company’s business or its actual or demonstrably anticipated research or development, including
without limitation (a) trade secrets, mask works, ideas, processes, formulas, source and object codes, data, programs, other works of authorship, know-how, improvements, discoveries, developments, designs and techniques; (b) information
regarding plans for research, development, new products and services, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers; (c) information regarding the skills
and compensation of other employees, contractors, and any other service providers of Company; and (d) the existence of any business discussions, negotiations, or agreements between Company and any third party. 

(c)    Third Party Information. I understand that Company has received and in the future will receive from third parties
confidential or proprietary information (“Third Party Information”) subject to a duty to maintain the confidentiality of such information and to use it only for certain limited purposes. During the term of my employment and thereafter, I
will hold Third Party Information in the strictest confidence and will not disclose to any person, firm or corporation (other than Company personnel who need to know such information in connection with their work for Company) or use it except as
necessary in carrying out my work for Company consistent with Company’s agreement with such third party or unless expressly authorized by an officer of Company in writing. 

(d)    Former Employer Information. I represent that my employment by Company does not and will not breach any agreement with any
former employer, including any non-compete agreement or any agreement to keep in confidence or refrain from using information acquired by me prior to my employment by Company. I further represent that I have not entered into, and will not enter
into, any agreement, either written or oral, in conflict with my obligations under this Agreement. I will not, during my employment with Company, improperly use or disclose any confidential information or trade secrets of any former or concurrent
employer or other person or entity and that I will not bring onto the premises of Company, or upload onto the Company’s systems, any unpublished documents or confidential information belonging to any such employer, in violation of any lawful
agreements with such employer, person or entity. I will use in the performance of my duties only information that is generally known and used by persons with training and experience comparable to my own, is common knowledge in the industry or
otherwise legally in the public domain, or is otherwise provided or developed by Company. 

  

					
	initial CIPA	  	1 of 8	  	Last Revised 8.5.2016            

 

 
  

	2.	 Assignment of Inventions. 

(a)    Definitions. As used in this Agreement, the term “Invention(s)” means any ideas, concepts, information, materials,
processes, data, programs, know-how, improvements, discoveries, developments, designs, artwork, formulae, other copyrightable works, and techniques and all Intellectual Property Rights in any of the items listed above. The term “Intellectual
Property Rights” means all trade secrets, copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any jurisdiction or country. The term “Moral Rights” means all paternity,
integrity, disclosure, withdrawal, special and any other similar rights recognized by the laws of any jurisdiction or country. 

(b)    Prior Inventions. I have set forth on Exhibit A (Inventions) a complete list of all Inventions that I have, alone or jointly
with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my employment with Company, in which I have an ownership interest or which I have a license to use and
that I wish to have excluded from the scope of this agreement (collectively referred to as “Prior Inventions”). If no Prior Inventions are listed in Exhibit A, I warrant that there are no Prior Inventions. If, in the course of my
employment with Company, I incorporate a Prior Invention into a Company product, process or machine, I hereby grant Company a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights
to sublicense through multiple tiers of sublicensees) to reproduce, make derivative works of, distribute, publicly perform, publicly display in any form or medium, whether now known or later developed, make, have made, modify, use, sell, import,
offer for sale, and exercise any and all present or future rights in, such Prior Invention. Notwithstanding the foregoing, I agree that I will not incorporate, or permit to be incorporated, any Prior Inventions in any Company Inventions (as defined
below) without Company’s prior written consent. 
 (c)    Assignment of Inventions. Subject to Sections 2(d) and 2(f), I
hereby assign and agree to assign in the future (when any such Inventions or Intellectual Property Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to Company all my right, title and interest in and to any and
all Inventions (and all Intellectual Property Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned by me, either alone or jointly with others,
during the period of my employment with Company. Inventions assigned to Company, or to a third party as directed by Company pursuant to Section 2(f) are referred to as “Company Inventions.” I further agree that all original works of
authorship which are made by me (solely or jointly with others) within the scope of and during the period of my employment and which are protectable by copyright are “works made for hire,” as that term is defined in the United States
Copyright Act. Any assignment of Inventions (and all Intellectual Property Rights with respect thereto) hereunder includes an assignment of all Moral Rights. To the extent such Moral Rights cannot be assigned to Company and to the extent the
following is allowed by the laws in any country where Moral Rights exist, I hereby unconditionally and irrevocably waive the enforcement of such Moral Rights, and all claims and causes of action of any kind against Company or related to
Company’s customers, with respect to such rights. I further acknowledge and agree that neither my successors-in-interest nor legal heirs retain any Moral Rights in any Inventions (and any Intellectual
Property Rights with respect thereto). 
 (d)    Nonassignable Inventions. I understand that this agreement does not apply to an
Invention which I can prove qualifies fully as a nonassignable Invention under applicable law. I have reviewed the Limited Exclusion Notification section on Exhibit A (Inventions) and agree that my signature on this agreement acknowledges receipt of
the notification. 

  

					
	initial CIPA	  	2 of 8	  	Last Revised 8.5.2016            

 

 
  

 (e)    Obligation to Keep Company Informed. During the period of my employment and
for one (1) year after termination of my employment with Company, I will promptly disclose to Company in writing all Inventions authored, conceived or reduced to practice by me, either alone or jointly with others, including any that may qualify as
a nonassignable Invention under applicable law. In addition, I will promptly disclose to Company all patent applications filed by me or on my behalf, or in which I am named as an inventor or co-inventor, within a year after termination of
employment. At the time of each such disclosure, I will advise Company in writing of any Inventions that I believe fully qualify as nonassignable under applicable law; and I will at that time provide to Company in writing all evidence necessary to
substantiate that belief. Company will keep in confidence and will not use for any purpose or disclose to third parties without my consent any confidential information disclosed in writing to Company pursuant to this Agreement relating to Inventions
that qualify fully as nonassignable under the provisions of applicable law. 
 (f)    Government or Third Party. I agree to
assign all my right, title and interest in and to any particular Company Invention to a third party, including without limitation the United States, as directed by Company. 

(g)    Enforcement of Intellectual Property Rights. During and after the period of my employment and at Company’s request and
expense, I will assist Company in every proper way, including consenting to and joining in any action, to obtain and enforce United States and foreign Intellectual Property Rights and Moral Rights relating to Company Inventions in all countries. If
Company is unable to secure my signature on any document needed in connection with such purposes, I hereby irrevocably designate and appoint Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is
coupled with an interest, to act on my behalf to execute and file any such documents and to do all other lawfully permitted acts to further such purposes with the same legal force and effect as if executed by me. 

3.    Records. I agree to keep and maintain adequate and current records of all Inventions developed by me (solely or
jointly) during the period of my employment at Company. The records shall be available to and remain the sole property of Company at all times. 

4.    Unfair Competition. I understand and agree that Company is engaged in a highly competitive
business and has expended, and continues to expend, significant resources to develop and maintain valuable customer and employee relationships, Proprietary and Confidential Information, and good will in the business community and the marketplace it
serves. I understand and agree that my work for Company will bring me into close contact with many Company customers and employees, and it will provide me access to Proprietary and Confidential Information. Accordingly, I further agree that the
covenants in this Agreement are reasonable and necessary to protect Company’s legitimate business interests in its customer and employee relationships, its good will, and its Proprietary and Confidential Information. To protect these legitimate
interests, I agree as follows: 
 (a)    Solicitation of Employees. I agree that for the period of my employment by Company and
for twelve (12) months after the date of termination of my employment I will not, either directly or indirectly, solicit, or attempt to solicit, or participate in the solicitation of, any employee, independent contractor or consultant of
Company to terminate his or her relationship with Company in order to become an employee, consultant or independent contractor to or for any other person or entity. This restriction is limited to those Company employees, consultants, and independent
contractors (i) who held such status with Company as of the date of my termination of employment or (ii) who would have held such status as of the date of my termination of employment but for my having encouraged or solicited them to
terminate their employment. 

  

					
	initial CIPA	  	3 of 8	  	Last Revised 8.5.2016            

 

 
  

 (b)    Solicitation of Customers. I agree that for the period of my employment by
Company and for twelve (12) months after the date of termination of my employment, I will not solicit the business of any customer of Company for any other business, individual, or party that competes with the products and services offered by
Company. “Customer” means any person or entity (i) that is doing business with Company at the time of my termination, or has done business with Company during the twelve (12) month period immediately preceding termination of my
employment, and (ii) for which I provided any services, or for which I was responsible for the provision of services by others, or about which I had access to Proprietary or Confidential Information during the twelve (12) month period
immediately preceding my termination. If I am employed by Company in California, this provision shall only apply for the period of my employment by Company and shall not apply following the termination of my relationship with Company. 

(c)    Covenant Not to Compete. I agree that during the course of my employment and for twelve (12) months following the
termination of my relationship with Company by either party for any reason, I will not , directly or indirectly, as a partner, employee, officer, director, agent, investor, owner, consultant or otherwise, solicit, perform or provide, or attempt to
perform or provide Conflicting Services (defined below) anywhere in the Territory (defined below), nor will I assist another person to solicit, perform or provide or attempt to perform or provide Conflicting Services anywhere in the Territory. If I
am employed by Company in California, this provision shall only apply for the period of my employment by Company and shall not apply following the termination of my relationship with Company. 

(d)    Reasonableness of Restrictions. For purposes of this Agreement, “Conflicting Services” means any product, service,
or process or the research and development thereof, of any person or organization other than Company that directly competes with a product, service, or process, including the research and development thereof, of Company with which I worked directly
or indirectly during my employment by Company or about which I acquired Proprietary or Confidential Information during my employment by Company. For purposes of this Agreement, “Territory” shall mean any geographic area for which I had
functional or actual responsibility during the twelve (12) month period immediately preceding the termination of my employment, as well as any area for which my knowledge of Confidential Information jeopardizes Company’s interest in
protecting that information. Nothing contained herein shall prohibit me from being the passive owner of not more than 1% of the outstanding stock of any class of a corporation which is engaged in a competitive business of Company and which is
publicly traded. Nothing contained herein shall prohibit me from seeking a waiver from Company of these obligations at the time of any termination and waiver will not be unreasonably withheld. I acknowledge that my fulfillment of the obligations
contained in this agreement is necessary to protect Company’s legitimate interests and, consequently, to preserve the value and goodwill of Company. I further acknowledge the time, geographic and scope limitations of my obligations under this
section are reasonable and represent restrictions which are no greater than necessary so as to afford Company the opportunity to protect its legitimate interests. Further, I acknowledge that employment opportunities exist such that I can be
gainfully employed without violating these restrictions. 
 (e)     Non-Disparagement. During
Employee’s employment with the Company and thereafter, Employee will not make, issue, release or authorize any written or oral statements, derogatory or defamatory in nature, about the Company or its subsidiaries or their respective
stockholders, members, directors, managers, officers or employees. However, nothing in this paragraph prohibits Employee from making truthful statements required by legal process issued by a court or tribunal of competent jurisdiction, and/or to any
federal, state, or local government agency. 

  

					
	initial CIPA	  	4 of 8	  	Last Revised 8.5.2016            

 

 
  

 5.    No Conflicting
Obligation. I represent that I have not entered into any agreements and am not subject to any duties to third parties, which are inconsistent with the terms of this agreement. I agree that, during my employment with Company,
I will not without Company’s express written consent, engage in any other employment, occupation, consulting or other business activity directly related to the business in which Company is now involved or becomes involved during my employment,
nor will I enter into any agreements or commitments or engage in any other activities that conflict with my obligations to Company. 

6.    Return of Company Documents. When I leave the
employ of Company or upon Company’s request at any other time, I will deliver to Company all of Company’s property, equipment, drawings, notes, memoranda, specifications, devices, formulas, and documents, together with all copies thereof,
and any other material containing or disclosing any Inventions, Third Party Information or Confidential Information of Company and certify in writing that I have fully complied with the foregoing obligation. I agree that I will not copy, delete, or
alter any information contained upon my Company computer or Company equipment before I return it to Company. In addition, if I have used any personal computer, server , or e-mail system to receive, store, review, prepare or transmit any Company
information, including but not limited to Confidential Information, I agree to provide the Company with a computer-useable copy of all such Confidential Information and then permanently delete and expunge such
Confidential Information from those systems; and I agree to provide the Company access to my system as reasonably requested to verify that the necessary copying and/or deletion is completed. I further agree that any property situated on
Company’s premises and owned by Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company personnel at any time with or without further notice. 

7.    Notification of New Employer. In the event that
I leave the employ of Company, I hereby consent to the notification of my new employer of my rights and obligations under this agreement, but Company providing a copy of this Agreement or otherwise. 

 

	8.	 General Provisions. 

(a)    Governing Law; Consent to Personal Jurisdiction. This Agreement will be governed by and construed according to the laws of
the State of Utah, without giving effect to any conflict of laws principles that require the application of the law of a different state. I expressly consent to the exclusive personal jurisdiction and venue in the state and federal courts located in
the County of Salt Lake, State of Utah, for any litigation related to or arising from this Agreement or related to the employment relationship between the parties. 

(b)    Defend Trade Secrets Act of 2016 Notice. Under the federal Defend Trade Secrets Act of 2016, Employee shall not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an
attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made to Employee’s attorney in relation to a lawsuit for retaliation against Employee for reporting a suspected violation
of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. 

(c)    Severability. If one or more of the provisions in this Agreement are deemed invalid or unenforceable for any reason, the
parties agree that the court should modify the provision to the minimum extent necessary to render said provision enforceable. Should any court of competent jurisdiction determine that any provision of this Agreement is unenforceable and cannot be
modified to be enforceable, that provision shall become void, leaving the remaining provisions in full force and effect. 

  

					
	initial CIPA	  	5 of 8	  	Last Revised 8.5.2016            

 

 
  

 (d)    Successors and Assigns. This Agreement will be binding upon my heirs,
executors, administrators and other legal representatives and will be for the benefit of Company, its successors, and its assigns. 

(e)    Survival. The provisions of this Agreement shall survive the termination of my employment and the assignment of this
Agreement by Company to any successor in interest or other assignee. 
 (f)    Employment. I agree and understand that nothing in
this agreement shall confer any right with respect to continuation of employment by Company, nor shall it interfere in any way with my right or Company’s right to terminate my employment at any time, with or without cause and with or without
advance notice. 
 (g)    Notices. Any notices required or permitted hereunder shall be given to the appropriate party at the
address specified below or at such other address as the party shall specify in writing. Such notice shall be deemed given upon personal delivery to the appropriate address or if sent by certified or registered mail, three (3) days after the
date of mailing. 
 (h)    Legal and Equitable Remedies. Because my services are personal and unique and because I may have
access to and become acquainted with the Confidential Information of Company, any breach of this Agreement by me would cause irreparable injury to the Company for which monetary damages would not be an adequate remedy and, therefore, Company shall
have the right to enforce this Agreement and any of its provisions by temporary, preliminary, and permanent injunction, specific performance or other equitable relief, without bond and without prejudice to any other rights and remedies that Company
may have for a breach of this agreement. 
 (i)    Waiver. No waiver by Company of any breach of this Agreement shall be a waiver
of any preceding or succeeding breach. No waiver or failure by Company to enforce any right under this Agreement shall be construed as a waiver of that right or any other right on any other occasion. Company shall not be required to give notice to
enforce strict adherence to all terms of this agreement. 
 (j)    Export. I agree not to export, reexport, or transfer, directly
or indirectly, and U.S. technical data acquired from Company or any products utilizing such data, in violation of the United States export laws or regulations. 

(k)    Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and all
of which shall be taken together and deemed to be one instrument. 
 (l)    Entire Agreement. The obligations pursuant to
Sections 1 and 2 of this agreement shall apply to any time during which I was previously employed, or am in the future employed, by Company as a consultant if no other agreement governs nondisclosure and assignment of Inventions during such period.
This Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior communications between us with respect to such matters. No modification of or amendment to
this Agreement, other than by a court pursuant to paragraph (c) of this Section 8, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by me and the CEO of Company. Any subsequent change or
changes in my duties, salary or compensation will not affect the validity or scope of this Agreement. 
 [Signature Page to Follow] 

  

					
	initial CIPA	  	6 of 8	  	Last Revised 8.5.2016            

 

 
  

 I have read this Agreement carefully and understand and accept its terms, and have been given the opportunity
to review it with independent legal counsel. I have completely filled out Exhibit A to this agreement. This Agreement shall be effective as of the first day of my employment with Company. 

 

			
	EMPLOYEE:
	
	 /s/ Steve Daly

	Signature
	
	Steve Daly
	  

	Printed Name
	
	 Accepted and Agreed To:
  

INSTRUCTURE, INC.:

		
	By:	 	 /s/ Jeff Weber

	
	 EVP People and Places
 6330 South
3000 East, Suite 700

	Salt Lake City, UT 84121

  

					
	initial CIPA	  	7 of 8	  	Last Revised 8.5.2016            

 

 
  

 Exhibit A 

INVENTIONS 

1.    Prior Inventions Disclosure. The following is a complete list of all inventions or improvements relevant to the
subject matter of my employment by Instructure, Inc. (“Company”) that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by Company. If no Prior Inventions are listed below, I
represent that there are no Prior Inventions. 
  

                          
                                         
                                         
     
  

                          
                                         
                                         
     
  

                          
                                         
                                         
     
  

                          
                                         
                                         
     
  

                          
                                         
                                         
     
  

	2.	 Limited Exclusion Notification. 

This is to notify you pursuant to applicable law, which could include applicable statutory restrictions on the assignment of inventions under the laws of
California, Illinois, Washington and Utah, that the foregoing Agreement between you and Company does not require you to assign or offer to assign to Company any invention that you conceived, developed, reduced to practice or created entirely
(1) outside of your scope of employment, (2) completely on your own time; and (3) without using Company’s equipment, facilities, supplies, resources or intellectual property except for those inventions that either: 

1. Relate at the time of conception or reduction to practice of the invention to the current or demonstrably anticipated business, research, or development of
Company; or 
 2. Result from any work, services, or duties performed by you for Company. 

See, e.g., Utah Code Title 34, Chapter 39, Section 2 (U.C.A. 34-39-2) or California Labor Code 2870. 

  

					
	initial CIPA	  	8 of 8	  	Last Revised 8.5.2016

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]